Viruses and hepatocellular carcinoma.
作者信息
Sherlock S
机构信息
Department of Surgery, Royal Free Hospital School of Medicine, London.
出版信息
Gut. 1994 Jun;35(6):828-32. doi: 10.1136/gut.35.6.828.
Abstract
摘要
相似文献
1
Viruses and hepatocellular carcinoma.病毒与肝细胞癌
Gut. 1994 Jun;35(6):828-32. doi: 10.1136/gut.35.6.828.
2
[Liver cancer--a disease caused by virus?].[肝癌——一种由病毒引起的疾病？]
Lakartidningen. 1991 Jun 12;88(24):2239-41.
3
Hepatocellular carcinoma.肝细胞癌
Clin J Oncol Nurs. 2002 Mar-Apr;6(2):107-8. doi: 10.1188/02.CJON.107-108.
4
Hepatitis viruses as aetiological agents of hepatocellular carcinoma.肝炎病毒作为肝细胞癌的病原体。
Ital J Gastroenterol. 1991 Sep-Oct;23(7):452-6.
5
Perspective: incision revision.观点：切口修复。
Nature. 2014 Dec 4;516(7529):S17. doi: 10.1038/516S17a.
6
Viral pathogenesis of hepatocellular carcinoma.肝细胞癌的病毒发病机制
J Gastroenterol Hepatol. 2002 Dec;17 Suppl 3:S413-20. doi: 10.1046/j.1440-1746.17.s3.37.x.
7
Hepatocellular carcinoma in Pakistan.巴基斯坦的肝细胞癌
J Coll Physicians Surg Pak. 2013 Nov;23(10):769-70.
8
Pathobiology of chronic hepatitis virus infection and hepatocellular carcinoma (HCC).慢性肝炎病毒感染与肝细胞癌（HCC）的病理生物学
Ital J Gastroenterol. 1991 Nov;23(8):498-502.
9
Hepatocellular carcinoma: the need for progress.肝细胞癌：取得进展的必要性。
J Clin Oncol. 2005 May 1;23(13):2892-9. doi: 10.1200/JCO.2005.03.196.
10
[Hepatitis viruses and hepatocarcinogenesis].[肝炎病毒与肝癌发生]
Gan To Kagaku Ryoho. 1993 May;20(7):858-63.
引用本文的文献
1
Inferior Outcomes Associated with the Coexistence of Hepatocellular Carcinoma Recurrence and Hepatic Virus Reinfection After Living Donor Liver Transplantation.肝移植后肝细胞癌复发和肝病毒再感染共存与不良结局相关。
J Gastrointest Surg. 2020 Feb;24(2):353-360. doi: 10.1007/s11605-019-04116-0. Epub 2019 Feb 4.
2
Helicobacter pylori Infection as a Risk Factor for Hepatocellular Carcinoma: A Case-Control Study in Ethiopia.幽门螺杆菌感染作为肝细胞癌的一个危险因素：埃塞俄比亚的一项病例对照研究。
Int J Hepatol. 2018 Dec 2;2018:1941728. doi: 10.1155/2018/1941728. eCollection 2018.
3
Time trend analysis of primary liver cancer incidence in Sihui county of Guangdong Province, China (1987-2011).中国广东省四会市原发性肝癌发病率的时间趋势分析（1987 - 2011年）
BMC Cancer. 2016 Oct 12;16(1):796. doi: 10.1186/s12885-016-2817-9.
4
Prevention of cancer recurrence after treatment for hepatitis C virus-related hepatocellular carcinoma by interferon therapy.干扰素治疗对丙型肝炎病毒相关肝细胞癌治疗后癌症复发的预防作用。
Clin J Gastroenterol. 2009 Apr;2(2):65-70. doi: 10.1007/s12328-009-0072-1. Epub 2009 Apr 8.
5
Th1/Th2 cytokines and their genotypes as predictors of hepatitis B virus related hepatocellular carcinoma.Th1/Th2细胞因子及其基因型作为乙型肝炎病毒相关肝细胞癌的预测指标
World J Hepatol. 2015 Jun 18;7(11):1572-80. doi: 10.4254/wjh.v7.i11.1572.
6
Golgi protein 73 as a biomarker for hepatocellular carcinoma: A diagnostic meta-analysis.高尔基体蛋白73作为肝细胞癌生物标志物的诊断性荟萃分析
Exp Ther Med. 2015 Apr;9(4):1413-1420. doi: 10.3892/etm.2015.2231. Epub 2015 Jan 29.
7
Diagnostic Performance of Des-γ-carboxy Prothrombin for Hepatocellular Carcinoma: A Meta-Analysis.去γ-羧基凝血酶原对肝细胞癌的诊断性能：一项荟萃分析。
Gastroenterol Res Pract. 2014;2014:529314. doi: 10.1155/2014/529314. Epub 2014 Aug 6.
8
Involvement of DNA damage response pathways in hepatocellular carcinoma.DNA损伤反应通路在肝细胞癌中的作用
Biomed Res Int. 2014;2014:153867. doi: 10.1155/2014/153867. Epub 2014 Apr 28.
9
Specific molecular signatures of non-tumor liver tissue may predict a risk of hepatocarcinogenesis.非肿瘤性肝组织的特定分子特征可能预示着肝癌发生的风险。
Cancer Sci. 2014 Jul;105(7):749-54. doi: 10.1111/cas.12431. Epub 2014 Jun 18.
10
Improvement of long-term outcomes in hepatitis C virus antibody-positive patients with hepatocellular carcinoma after hepatectomy in the modern era.在现代，肝切除术治疗后丙型肝炎病毒抗体阳性的肝细胞癌患者的长期预后得到改善。
World J Surg. 2011 May;35(5):1072-84. doi: 10.1007/s00268-011-1013-y.
本文引用的文献
1
Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies.原发性肝癌：48900例尸检中的100例研究。
Cancer. 1954 May;7(3):462-503. doi: 10.1002/1097-0142(195405)7:3<462::aid-cncr2820070308>3.0.co;2-e.
2
Liver transplantation in primary hepatocellular carcinoma.原发性肝细胞癌的肝移植
J Hepatol. 1993 Jun;18(2):151-3. doi: 10.1016/s0168-8278(05)80240-5.
3
A macroregenerative nodule containing multiple foci of hepatocellular carcinoma in a noncirrhotic liver.一个非肝硬化肝脏中的巨再生结节，包含多个肝细胞癌灶。
Hepatology. 1993 Jun;17(6):993-6.
4
Frequent loss of heterozygosity on chromosome 22 in hepatocellular carcinoma.肝细胞癌中22号染色体杂合性的频繁缺失。
Hepatology. 1993 May;17(5):794-9.
5
Liver resection for hepatocellular carcinoma. Results of 229 consecutive patients during 11 years.肝细胞癌的肝切除术。11年间229例连续患者的结果。
Ann Surg. 1993 Apr;217(4):375-84. doi: 10.1097/00000658-199304000-00009.
6
A comparative study of hepatic resection and transcatheter arterial embolization for the treatment of primary hepatocellular carcinoma.肝切除与经导管动脉栓塞术治疗原发性肝细胞癌的对比研究
Cancer. 1993 Apr 1;71(7):2181-6. doi: 10.1002/1097-0142(19930401)71:7<2181::aid-cncr2820710703>3.0.co;2-3.
7
Rationale of surgical management for recurrent hepatocellular carcinoma.复发性肝细胞癌的外科治疗原理
Ann Surg. 1993 Jan;217(1):28-34. doi: 10.1097/00000658-199301000-00006.
8
9
Risk factors for hepatocellular carcinoma among patients with chronic liver disease.慢性肝病患者肝细胞癌的危险因素。
N Engl J Med. 1993 Jun 24;328(25):1797-801. doi: 10.1056/NEJM199306243282501.
10
DNA image cytometric analysis of macroregenerative nodules (adenomatous hyperplasia) of the liver: evidence in support of their preneoplastic nature.肝脏大再生结节（腺瘤样增生）的DNA图像细胞计量分析：支持其癌前性质的证据
Hepatology. 1993 Apr;17(4):621-7. doi: 10.1002/hep.1840170416.
Zotero 插件